MAPT and Mental deterioration: To verify the consistency between the [18F]THK-5117 distribution, neuronal degeneration, and cognitive decline [22–24], the current tau PET findings should be compared with volumetric magnetic resonance (MR) and 2-[18F]fluoro-2-deoxy-D-glucose PET data in the future.